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Abstract
Background: Higher risks of asthma have been observed in children with prenatal 
exposure to antibiotics and during early life compared with those who have not. 
However, the causality of such associations is unclear.
Objective: To assess whether exposure to antibiotics in early life had a causal effect in 
increasing the risk of asthma in children diagnosed at 5– 8 years of life, and the impact 
in the target population.
Methods: Data were from electronic health records and questionnaires for children 
and their mothers in the Born in Bradford birth cohort. Exposure variables were pre-
scriptions of systemic antibiotics to the mother during pregnancy (prenatal) and to 
the children at 0– 24 months of life (postnatal). We assessed the association in 12,476 
children with several approaches to deal with different sources of bias (triangulation): 
the interactions with mother's ethnicity, mode of delivery, and between prenatal and 
postnatal exposures; dose- response; and estimated the population attributable risk.
Results: There was an association between prenatal exposure at 7– 27 days before the 
child's birth and asthma (adjusted OR = 1.40; 1.05, 1.87), but no association with the 
negative control exposure (before pregnancy) (adjusted OR = 0.99 (0.88, 1.12)). For 
postnatal exposure, the adjusted OR was 2.00 (1.71, 2.34), and for sibling analysis, it 
was 1.99 (1.00, 3.93). For postnatal exposure, the risk of asthma increased with the 
number of prescriptions. The observed effect of both exposures was lower among 
children with mothers of Pakistani ethnicity, but inconclusive (p > .25). The inter-
action between prenatal and postnatal exposures was also inconclusive (p = .287). 
The population attributable risk of postnatal exposure for asthma was 4.6% (0.1% for 
prenatal).
Conclusions: We conclude that the associations between both late- pregnancy prena-
tal exposure to antibiotics and postnatal exposure to antibiotics and an increased risk 
of asthma are plausible and consistent with a causal effect.
K E Y W O R D S
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1  |  INTRODUC TION
There is evidence that children whose mothers received antibiotics 
during pregnancy (prenatal exposure), and children who were ex-
posed to antibiotics in early life (postnatal exposure), are at higher 
risk of allergic diseases and asthma.1– 4 However, it is not clear to 
what extent this association is due to bias or is a causal association. 
Causal mechanisms are plausible: antibiotics taken by the mother 
in pregnancy and passed to her child, or taken by the child in early 
infancy, can lead to a Th- 2 skewed immune response and asthma.5,6 
Given that most cases of asthma in the UK are allergic, it is plausible 
that changes in the immune system are a common ultimate proximal 
causal pathway shared by prenatal and postnatal antibiotic expo-
sures. However, not all cases of asthma are allergic, and so, there 
can be different causal mechanisms in different asthma sub- types.7 
If it is a causal association, this is important from a public health per-
spective, given the large proportion of pregnant women and chil-
dren who use antibiotics (33% and 70%, respectively, estimated for 
our target population), and the high prevalence of asthma in many 
settings.7
However, there is also evidence that this association with antibi-
otics can be due to unmeasured confounders. For example, maternal 
exposure to antibiotics before pregnancy,8– 10 and paternal expo-
sure9 have been reported as associated with asthma. Furthermore, it 
has been described that this association between prenatal and post-
natal antibiotics and asthma decreased when assessed with sibling 
analysis that controls for shared familial and indoor environmental 
factors.11
In our observational study, we investigated whether prenatal and 
postnatal exposure to antibiotics had a causal association with an in-
creased risk of asthma in children recruited to the Born in Bradford 
birth cohort study in England (BiB cohort).12 We used several 
approaches to deal with different sources of bias and to assess 
causation (i.e., triangulation)13: maternal prescriptions 0– 12 months 
before pregnancy were used as negative control exposure, the anal-
ysis was repeated excluding children with lower respiratory infec-
tion and/or asthma at 0– 4 years to avoid reverse causation with 
postnatal antibiotic exposure, and sibling analysis was conducted 
to control for prenatal shared time- invariant maternal and environ-
mental factors. We also assessed the heterogeneity of effects by 
mother's ethnicity and interaction between prenatal and postnatal 
exposures, and the disease burden.
2  |  METHODS
The target population was 25,534 children born at the Bradford 
Royal Infirmary between 2007 and 2011, of which 13,858 (54%) 
were recruited to the BiB cohort.12,14 We included all children of the 
BiB cohort except 173 children who died. The study population was 
the 13,685 children alive at the time of this study, from 12,248 moth-
ers (1,384 mothers had >1 child). The complete case analyses with 
Methodology
Born in Bradford birth cohort
Procedures:
• Multivariable regression
• Negative exposure control
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12,476 children born 
2007-2011
Outcome
Asthma in children at 5-8 
years of age
Exposure
Systemic antibiotic prescriptions 
to mothers (pregnancy) and to 
children 0-24 months of life
Results
Adjusted OR = 1.40 (1.05, 1.87) Adjusted OR = 2.00 (1.71, 2.34)
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G R A P H I C A L  A B S T R A C T
• Asthma in children was positively associated with prenatal and postnatal antibiotic prescriptions.
• These associations were observed after procedures to minimize bias and not observed with exposure to antibiotics before pregnancy.
• We conclude that these findings support causal effects in our target population.
Key messages
• Asthma in children was positively associated with pre-
natal and postnatal antibiotic prescriptions.
• These associations were observed after procedures to 
minimize bias and not observed with exposure to antibi-
otics before pregnancy.
• We conclude that these findings support causal effects 
in our target population.
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multivariable logistic regression (MLR) was conducted with 12,476 
children, of whom 2,622 were siblings (284 twins) (Figure 1). 2,826 
of 12,476 were born by caesarean section, and the mothers of 89 
children received intrapartum antibiotic prophylaxis to prevent 
post- surgical site infection. Every pregnant woman who attended 
Bradford Royal Infirmary antenatal clinic between 2007 and 2011 
was invited to take part in the BiB cohort. Consenting women signed 
a consent form.
2.1  |  Sources of data
Data on ethnicity, socio- economic and lifestyle factors were ob-
tained from a baseline questionnaire administered at recruitment 
during pregnancy. Primary care clinical event and prescription 
data were obtained from linked electronic health records (EHR).15 
Obstetric and birth data were extracted from the hospital electronic 
maternity records, and data on children's body mass at 4– 5 years 
were taken from the National Child Measurement Programme.
2.2  |  Outcome definition
We conducted case- insensitive text mining of the EHR for the term 
“asthma”. Of the 162 Read codes found (diagnostic codes that are 
used in primary care in the UK), we selected 148 to define asthma 
(Table S1), including Read codes validated in previous studies.16 We 
used two case definitions. For the first, a child was a case if they 
had ≥1 of the selected Read codes from 5 to 8 years of age, as the 
diagnosis of asthma before 5 years old is difficult.17 For the second 
definition, we searched for GP prescriptions for inhaled corticoster-
oids, bronchodilators and leukotriene receptor antagonists identi-
fied by text mining and British National Formulary (BNF) codes. We 
defined an asthma case if a child fulfilled the first definition and had 
≥1 prescription for inhaled corticosteroids or leukotriene receptor 
antagonists between 5 and 8 years of age; this definition would have 
higher specificity than the first definition.
2.3  |  Exposure
We searched the EHR for generic and common brand names of oral 
and systemic antibiotics (case- insensitive text mining), and BNF 
codes. We classified maternal exposure during pregnancy (prenatal 
exposure) as four dichotomous variables: first trimester (<93 days of 
gestational age); second trimester (93– 184 days); third trimester until 
28 days before the child's birth; and the period 7– 27 days before the 
child's birth (see Table S2). Maternal prescriptions at 0– 12 months 
before pregnancy were used as the negative control exposure, under 
the assumption it is associated with the same confounders that are 
F I G U R E  1  Derivation of the study 
population
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associated with maternal exposure during pregnancy, but with an 
implausible causal effect with asthma in the child.18 Postnatal ex-
posure was defined as a child's prescriptions of systemic antibiotics 
between 0 and 24 months old.
2.4  |  Covariates
We first drew a directed acyclic graph with the main risk factors for 
asthma and then selected the variables related to the following: (1) 
the mother (history of asthma, eczema or hayfever, smoking, self- 
defined ethnicity, country of birth, age at child's birth, education, 
employment, diabetes during pregnancy, parity); (2) family size and 
(3) children (mode of delivery, obesity at 4– 5 years old, prematurity 
(<37 weeks gestation), low birthweight (<2,500 g), gender, lower 
respiratory tract infection (LRTI) between birth and 24 months old 
(defined as EHR records with the terms “lower respiratory tract in-
fection”, “pneumonia”, “syncytial infection” or “lower respiratory in-
fection”). Maternal history of asthma and child's gender were always 
maintained in the regression models.
2.5  |  Statistical analysis
Figure 2 shows the graphical representation. All the analyses ap-
plying the triangulation approach13 described below were done for 
the 1st asthma definition and only the association analysis for the 
2nd definition. Analyses were performed with Stata (Stata/SE 15 for 
Windows; StataCorp LP) and R statistical software (R Foundation).
Association analysis. First, we selected the variables that to-
gether in a regression resulted in ⪅10% of missing data. These 
variables were used in the complete case analysis (CCA) with MLR. 
Secondly, we conducted unadjusted associations between all vari-
ables in the CCA and the outcome (bivariable screening). Finally, 
all variables with unadjusted P value of ⪅0.25 were used to create 
five logistic regression models. Model 1 contained antibiotic expo-
sure during pregnancy and other variables. In model 2, the negative 
control exposure was added to model 1. In model 3 (full adjusted 
model), postnatal exposure was added to model 2. In model 4, chil-
dren with LRTI and/or asthma between 0 and 4 years were excluded 
from model 3 to avoid reverse causation with postnatal exposure. 
Model 5 (minimally adjusted model) was derived from model 3 after 
F I G U R E  2  Strategy of analysis to assess associations between exposure to antibiotics and asthma. After the directed acyclic graph, 
we selected the available variables representing the factors with a strong association with the outcome and their proxies based on a 
hypothetical causal framework. The analysis started with an exploratory data analysis to describe missing data, extreme values, sparse data, 
conflicting data from different sources and multicollinearity
    |  5CUNHA et Al.
backward elimination (package “abe” in R),19 based on change- in- 
estimate of odds ratio (OR) ⪆10% and without using statistical sig-
nificance. We also ran a matched analysis with conditional logistic 
regression with groups of siblings from the same mother, to control 
for shared time- invariant maternal and environmental factors.20
We estimated the E- value: “the minimum strength of association, 
on the risk ratio scale, that an unmeasured confounder would need 
to have with both the [exposure] and the outcome to decrease the 
association to the null (RR = 1).”21 The interaction between prenatal 
and postnatal exposures, and heterogeneity of effects according to 
the mother's ethnicity (the distribution of the risk factors for asthma 
vary in relation to ethnicity22) and mode of delivery (caesarean vs. 
vaginal) were assessed with log- binomial regression due to the high 
prevalence of asthma. The risk of disease in the population due to 
the exposure (population attributable risk, PAR),23 the population 
attributable fraction and the excess number of cases of asthma in 
the target population attributable to antibiotics were estimated for 
different hypothetical scenarios if the antibiotics had no effect on 
the asthma cases (Stata commands punaf and regpar).24
We conducted sensitivity analyses to assess the following: as-
certainment bias (stratification by the total number of days with 
GP visits or to the clinics a child had between 0 and 24 months old, 
excluding days with records on asthma, wheeze and LRTI); cluster-
ing effect (robust variance estimator, mothers as clusters); effect 
of each variable excluded from the MLR (missing data or bivariable 
screening); and effect of breastfeeding, positive skin prick test, child 
care and pets, with data available in subgroups of the BiB cohort22,25 
(unmeasured confounders).26,27
3  |  RESULTS
The CCAs were conducted on 12,476 children (Table 1). Differences 
were observed between CCA and 151 children with missing data, 
especially in relation to lower proportion of children whose mothers 
were born in the UK, mothers not employed and higher maternal 
education. In the CCA, 10.6% (n = 1,322) of children had asthma, 
46.3% (n = 5,774) had mothers of Pakistani heritage, and 46.1% 
(n = 5,746) had mothers born outside the UK.
3.1  |  Initial data analysis
In the 12,476 children, several factors were associated with an in-
creased risk of asthma, in addition to maternal and postnatal expo-
sure to antibiotics (Table S3): they were related to children (male, 
born by caesarean section, low birthweight, prematurity, obesity 
at 4 years old and LRTI in infancy) and to the mother and family 
(Pakistani origin, history of allergic diseases, not born in the UK, not 
being employed at baseline and as number of people in the house-
hold increased).
3.2  |  Association between exposure to 
antibiotics and childhood asthma
In the unadjusted association, the risk of asthma was higher among 
children whose mothers received antibiotics at 0– 12 months before 
pregnancy (negative control exposure) and in each trimester of preg-
nancy, and among children exposed to antibiotics at 0– 24 months 
old (Table 2). However, in the fully adjusted model (model 3), the 
ORs decreased and became closer to 1 (95% CI 0.9, 1.10), except 
for exposure during pregnancy at 7– 27 days before birth, OR = 1.40 
(1.05, 1.87), and at 0– 24 months old (postnatal exposure), OR = 2.00 
(1.71, 2.34) (Table 2). When children with previous lower respira-
tory disease were excluded (model 4), the OR decreased, but the 
association was still evident for the exposure at 0– 24 months old, 
OR = 1.67 (1.39, 2.01). Results for the second definition are pre-
sented in Table S4. These associations were observed for all classes 
of antibiotics, but the small numbers did not allow further compari-
sons between these different classes (Table 3).
The risk of asthma increased as the number of prescriptions of 
any antibiotics at 0– 24 months increased, however with overlapping 
confidence intervals (Table 4). Analysis of dose- response with expo-
sure during pregnancy at 7– 27 days before birth was not conducted 
due to small numbers.
Adjustment for clustering effect and the variables excluded from 
the CCA changed the OR between −0.7% and +15% in comparison 
with the fully adjusted model (model 3 in Table 2). The exception 
was with the association with childhood exposure at 0– 24 months 
old after the adjustment for previous GP consultations: the OR was 
2.00 (1.71, 2.34) in model 3 and 1.55 (1.32, 1.82) when adjusted for 
GP consultations.
Analysis of siblings. For maternal exposure at 7– 27 days before 
the birth, there were 11 groups of siblings with 2 children (22 chil-
dren) and 1 group with 3 children; for exposure of the children at 
0– 24 months old, there were 172 groups of siblings with 2 children 
(344 children) and 4 groups with 3 children. The estimates were ad-
justed for variables not shared by the siblings (child's gender, mode 
of delivery, child obesity at 4 years, low birthweight and maternal 
age at birth). There was a higher risk of asthma among those chil-
dren exposed at 0– 24 months with OR = 1.99 (1.00, 3.93) (Table S5). 
Results for maternal exposure had small numbers of children and 
therefore were difficult to interpret.
3.3  |  Sensitivity bias analysis
The adjusted risk ratio (Table S6) varied from 1.31 to 1.47 for pre-
natal exposure and from 1.71 to 1.89 for postnatal exposure. The 
biggest percent change- in- estimate was with skin prick test (SPT) 
and for prenatal exposure: the relative risk would be >+10.2% with 
adjustment (from 1.32, 1.47). There were no remarkable changes 
with child care, breastfeeding and presence of pets.
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TA B L E  1  Characteristics of the children separately for the study and analysed populations
Characteristics of the children and their mothers
Study population, N = 13,685
All children Children analyseda 
With valid data Missing N = 12,476
Child defined as asthma case at 5– 8 years old 1,406 (10.4) 151 1,322 (10.6)
Maternal antibiotic prescription:
0– 12 months before pregnancyb  4,735 (35.1) 190 4,531 (36.3)
1st pregnancy trimester 2,079 (15.4) 190 1,994 (16.0)
2nd pregnancy trimester 2,130 (15.8) 190 2,033 (16.3)
3rd trimester (≥28 days before the birth, range)c  1,392 (10.3) 190 1,336 (10.7)
3rd trimester (7– 27 days before the birth)c  425 (3.1) 190 392 (3.1)
All period of pregnancy (1st to 3rd trimester) 4,579 (33.5) 190 4,384 (35.1)
Child had antibiotic prescriptions at 0– 24 months old 9,459 (70.7) 298 8,872 (71.1)
Child's gender (male) 7,063 (51.6) 0 6,404 (51.3)
Mother with history of asthma 2,202 (16.3) 152 2,045 (16.4)
Mother with history of atopic eczema 3,718 (27.5) 152 3,508 (28.1)
Mother with history of hayfever 2,965 (21.9) 152 2,768 (22.2)
Mother with history of smoking:
During 1st pregnancy trimester 1,076 (7.9) 14 1,012 (8.1)
During 2nd pregnancy trimester, 3rd or both 635 (4.6) 14 581 (4.7)
During 0– 24 months of child's life 2,545 (18.6) 14 2,340 (18.8)
Child with obesity at 4– 5 years 1,206 (9.0) 232 1,133 (9.1)
Child with mother of Pakistani ethnicity (vs. others) 6,029 (45.4) 406 5,774 (46.3)
Mother with diabetes during pregnancyd  150 (1.1) 233 143 (1.1)
Mother born in the UK 7,185 (63.4) 2,361 6,730 (53.9)
Child born by caesarean section 3,058 (22.9) 355 2,826 (22.7)
Child had lower respiratory infection at 0– 24 months olde  293 (2.2) 155 270 (2.2)
Child born at <37 weeks of gestational age 842 (6.3) 322 764 (6.1)
Mother not employed at baseline 6,306 (55.8) 2,374 5,925 (47.5)
Maternal education higher than A level at baseline 2,889 (27.7) 3,262 2,651 (21.2)
Child with low birthweight (<2,500g) 1,112 (8.3) 323 1,033 (8.3)
Parity at child's birthf 
None 5,099 (39.6) 814 4,730 (37.9)
One 3,732 (29.0) 814 3,478 (27.9)
Two or more 4,040 (31.4) 814 3,803 (31.7)
Children with siblingsg  2,821 (20.6) 0 2,551 (30.5)
Number of people in household at baseline, mean (SD) 4.1 (2.3) 2,370 4.1 (2.3)
Maternal age at child birth (years), mean (SD) 27.5 (5.6) 0 27.6 (5.6)
aChildren included in the complete case analysis (CCA) with multivariable logistic regression.
bUsed as negative control exposure.
cAmong the 12,476 children, 1,336 mothers had prescriptions of antibiotics ≥28 days before the birth, 392 mothers 7– 27 days before the birth 
and (not in the table) 92 in both periods. The gestational age of birth for the 1,336 children was between 227 and 313 days, and between 197 and 
292 days for the 392 children.
dMother with prescriptions of insulin or other relevant drugs during pregnancy period, or ≥1 Read code for diabetes. It could be diabetes developed 
during pregnancy or pre- existent
eRecords with Read codes with the terms “lower respiratory tract infection”, “pneumonia”, “syncytial infection” or “lower respiratory infection” at 
0– 24 months old.
fNumber of previous parities identified by birth certification.
gNumber of children whose mothers had >1 child in the study population or analysed population.
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3.4  |  E- value
For the association with exposure at 7– 27 days before birth, the ob-
served OR was 1.40 and the E- value was RR = 2.15. Therefore, if the 
true value of the association were 1.0, an unmeasured confounder 
would need to have a RR of at least 2.15 with both exposure and 
asthma to produce the observed OR = 1.40. For postnatal exposure 
with OR = 1.67, the E- value was 2.73.
3.5  |  Heterogeneity of effect/interaction
The children who were exposed at 7– 27 days before birth (prena-
tal) and at 0– 24 months of life (postnatal) had a higher risk of dis-
ease (16.7%) in comparison with those with only prenatal exposure 
(10.5%) or only postnatal exposure (12.4%). The effect of exposure 
(RR) was lower among children whose mothers were of Pakistani 
ethnicity (prenatal: 1.31 (0.94; 1.81), postnatal: 1.83 (1.49; 2.24)) in 
TA B L E  3  Association between systemic antibiotic prescriptions and asthma (based only on Read codes between 5 and 8 yo) among 
12,476 children, separately for prenatal or postnatal exposure, and class of antibiotics
Systemic antibiotic prescriptions N Asthma case n (%)
Odds ratio adjusted (95% C.I.)
For one class of 
antibiotics a 
For all classes of 
antibioticsb 
To the mother 7– 27 days before birth c 
Penicillins
No 12,251 1,283 (10.5) 1 1
Yes 225 39 (17.3) 1.71 (1.20, 2.44) 1.71 (1.20, 2.44)
Cephalosporins
No 12,327 1,301 (10.6) 1 1
Yes 149 21 (14.1) 1.31 (0.82, 2.10) 1.30 (0.81, 2.08)
Others
No 12,442 1,319 (10.6) 1 1
Yes 34 3 (8.8) 0.79 (0.39, 2.60) 0.70 (0.21, 2.33)
To the child at 0– 24 months old
Penicillins
No 4,042 264 (6.5) 1 1
Yes 8,434 1,058 (12.5) 1.97 (1.71, 2.27) 1.72 (1.49, 1.99)
Cephalosporins
No 11,565 1,157 (10.0) 1 1
Yes 911 165 (18.1) 1.91 (1.59, 2.28) 1.49 (1.24, 1.79)
Macrolides
No 10,044 912 (9.1) 1 1
Yes 2,432 410 (16.9) 1.94 (1.71, 2.20) 1.67 (1.46, 1.90)
Others
No 12,207 1,279 (10.5) 1 1
Yes 269 43 (16.0) 1.68 (1.20, 2.34) 1.47 (1.05, 2.07)
aEach class of antibiotics each time and also adjusted for maternal history of asthma and child's gender.
bWith the variables for all classes of antibiotics together in the regression, and adjusted for maternal history of asthma and child's gender.
cThe variable on macrolides was excluded because there were no asthma cases among the exposed.
TA B L E  4  Percentage of asthma cases (based only on Read codes 
between 5 and 8 yo) at 5– 8 years old and the 95% confidence 
intervals, separately for number of prescriptions of any antibiotic 
to the children at 0– 24 months old, adjusted for maternal history of 
asthma and child's gender. N = 12,476
Number of 
prescriptions Asthma cases n/N (%)
% Adjusted 
(95% C.I.)
0 210/3604 (5.8) 6.0 (5.2, 6.8)
1 233/2842 (8.2) 8.3 (7.3, 9.3)
2 213/1945 (11.0) 10.9 (9.6, 12.3)
3 165/1368 (12.1) 11.9 (10.2, 13.6)
4 119/816 (14.6) 14.1 (11.8, 16.5)
5 96/588 (16.3) 16.0 (13.1, 18.9)
6 72/383 (18.8) 18.3 (14.5, 22.1)
7 62/295 (21.0) 20.2 (15.7, 24.7)
≥ 8 152/635 (23.9) 22.6 (19.5, 25.8)
Total 1,322/12,476 (10.6) 10.6 (10.1, 11.1)
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comparison with other ethnicities (prenatal: 1.53 (1.10; 2.14), post-
natal: 2.13 (1.75; 2.60)) and higher among children born by caesarean 
section (prenatal: 1.68 (1.13; 2.51), postnatal: 2.19 (1.63; 2.93)), in 
comparison with vaginal delivery (prenatal: 1.31 (0.99; 1.75), postna-
tal: 2.01 (1.71; 2.36)). All results had p > .25 for the interaction term.
3.6  |  Impact
Among the 12,476 children, 3.1% of the mothers received antibiotics 
during pregnancy at 7– 27 days before birth, and the excess number 
of asthma cases due to this exposure was estimated as 16 cases (33 
cases in the target population, 25,534, PAR = 0.1%, PAF = 1.2%) 
(scenario 1 in Table S7). 70% of children received antibiotics at 
0– 24 months old, and the excess number of cases was 569 cases 
(1,164 cases in 25,534, PAR = 4.6%, PAF = 43.0%) (scenario 2).
4  |  DISCUSSION
The two exposure variables, maternal antibiotics prescriptions at 
7– 27 days before the child's birth and prescriptions for the child 
at 0– 24 months, were associated with an increased risk of asthma, 
even after assessment for different biases: adjustment for relevant 
potential confounders, confounding by indication (LRTI), sibling 
analysis, reverse causation (postnatal exposure), sensitivity analysis 
for unmeasured confounders and ascertainment bias. There was no 
association with maternal antibiotic prescriptions before pregnancy, 
and so, the association was restricted to when a causal pathway was 
plausible. There was an increase in the risk of asthma with the in-
crease in the number of prescriptions (monotonic trend). The E- value 
was estimated as 2.15 and 2.73 (risk ratio scale). The results on het-
erogeneity of effects were considered inconclusive.
The association between antibiotic exposure and asthma has 
been observed previously: a literature review and meta- analyses by 
Zhao et al,28 which included papers from a previous review, showed 
a pooled OR of 1.22 (1.02, 1.45) for the whole pregnancy period 
(10 studies) but with high heterogeneity (I2 statistics = 90%), and so, 
the pooled OR is difficult to interpret. For the third trimester, it was 
1.33 (1.11, 1.60) (2 studies, I2 = 0%). Other studies published since 
this review also found an association,4,9,29– 31 with exceptions.32 
Evidence of dose- response has also been reported.10
In previous studies, similar associations were observed for an-
tibiotic exposure during, before and after pregnancy,8,10 and the 
association decreased with sibling analysis.11 These findings are in 
conflict with the causal hypothesis. However, in our study popula-
tion, neither antibiotics given to the mother before pregnancy was 
associated with asthma nor did the siblings’ analysis decrease or 
change the direction of the association. Therefore, in our study pop-
ulation the results were not conflicting.
The fact that the association was not observed before pregnancy 
gives support to specificity of the exposure during pregnancy.33 
Causal mechanisms have been suggested as biologically plausible: 
prenatal exposure to antibiotics by the mother and in early infancy 
could change the gut microbiome of the child and ultimately can lead 
to asthma.5 Alternatively, but not mutually exclusive, antibiotics can 
change the maternal microbiota, which are transmitted to the child 
and could lead to changes in the child's immune response.34 The di-
versity of the gut and lung microbiota of children would be disrupted, 
and reduced diversity and increased proportions of some specific 
pathogenic species have been associated with the development and 
severity of asthma.5,6,35,36 A similar process would be involved in the 
higher risk of asthma among children born by caesarean section,37 
and antibiotics and obesity in children.38 Therefore, there is evidence 
of this causal mechanism from other events. Heterogeneity of ef-
fects and “causal interaction” can be important to identify subgroups 
in which a hypothetical intervention would result in a larger effect 
and to shed light on an explanation for the causal effect.39 In the 
BiB cohort, the proportion of maternal smoking during pregnancy is 
higher in White British mothers than in mothers of Pakistani ethnic-
ity.22 However, it was not possible to reach a conclusion because of 
the high p value. We conclude that the associations between both 
late- pregnancy prenatal exposure to antibiotics and postnatal expo-
sure to antibiotics and an increased risk of asthma are plausible and 
consistent with a causal effect.
The strengths of this study are a large sample size, with detailed 
demographic data, and follow- up data through linkage with primary 
care data. Several relevant potential confounders were included 
such as indicators of heredity and respiratory infection in infancy. 
This study had a well- defined target population, which is important 
to make causal effects meaningful.40 Instead of trying to address 
our causal question based simply on a single regression model, we 
used triangulation.13 The variables representing maternal antibiotic 
exposure during pregnancy were defined after looking at the data, 
which could be considered a reason for the cautious interpretation 
of their associations with asthma.
Unmeasured confounding remains a possibility, and it is a poten-
tial limitation in an observational study.41 Relevant data such as on 
indoor environmental factors and breastfeeding were only available 
for sub- group of the study population, and thus, we conducted a bias 
analysis, but it does not replace an adjustment with the variables. If 
the magnitude of association is high, it is less likely to be explained 
by unmeasured confounders.42 We took the E- value as an indicator 
for the magnitude of association for this hypothetical confounding 
bias, by assuming that there would be one confounder that was not 
adjusted for, a strong assumption.43 Unmeasured confounders with 
magnitude of association with asthma could be higher than 2.044; 
therefore, confounding by an unmeasured confounder is plausible.
Evidence supporting a causal association is needed before pro-
posing public health interventions and changes in clinical practice. 
The decision- making process in public health ultimately is a subjec-
tive judgement considering our expectations of the benefits and 
harms based on evidence from different sources and including our 
current knowledge.45,46 In our study and target population, the at-
tributable excess number of cases would be small for prenatal expo-
sure at 7– 27 days before the birth, but this would be much higher for 
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postnatal exposure in early childhood, supporting the potential ben-
efits if exposure to antibiotics is reduced. As a caveat, the interpre-
tation of the excess number attributable to the exposure depends 
on whether the association is causal and whether elimination of the 
exposure has no effect on the distribution of other risk factors.47 
Furthermore, the excess number attributable to the exposure is not 
equal to the number of cases caused by the exposure.48
Evidence of any exposure- disease association depends also on 
the frequency of the different causes, and asthma results from the 
combination of several factors, which may not have the same dis-
tributions in different populations. Therefore, evidence of causation 
from a specific population is not necessarily generalizable to another 
population, consistency does not necessarily support causation,40 
and inconsistency in different studies is not necessarily due to meth-
odological issues. If there is good evidence of a causal association, 
whether the magnitude of the effect would justify a change in recom-
mendations and practice should be contextualized for different pop-
ulations, considering the trade- offs between the potential harms and 
benefits, and feasibility of reducing the consumption of antibiotics in 
infancy. For example, the decision to administer antibiotic prophy-
laxis to mothers during caesarean before the surgical cut to prevent 
surgical site infection should be balanced with the potential of long- 
term harm to their children's health.49 This more pragmatic approach 
should be considered, instead of trying to generalize the findings or 
wait for ultimate proof of a causal association or consistency of re-
sults from different settings. If, in a specific population, there is fair 
evidence of a significant effect from a public health perspective, and 
it is feasible to reduce the use of antibiotics, an intervention may be 
justified. Furthermore, these findings support the policy that seeks 
to minimize the usage of antibiotics in children,50 given the poten-
tial considerable numbers if our results were extrapolated to the UK 
population. In our target population, it would also be prudent to be 
judicious in the use of antibiotics in the last month of pregnancy.
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